Abstract:Vascular dementia is the second-most cause of dementia, characterized by cerebral infarcts, white matter lesions, myelin loss and often amyloid angiopathy. Hence, vascular damage is a critical cause of neuronal loss and synaptic disintegration. Abnormal neuroinflammation, autophagy and apoptosis are the prerequisite factors for endothelial and neuronal cell damage. This leads to the onset and progression of cerebrovascular disorders and cognitive dysfunction. The innate immune cells, pattern recognition receptors, Toll-like receptor-4 and related inflammatory mechanisms disrupt cerebrovascular integrity via glial activation and increased pro-inflammatory interleukins and TNFα. Inflammasome polymorphisms and multi-faceted neuro-immune interactions further integrate systemic and central inflammatory pathways, which induce vascular tissue injury and neurodegeneration. Specifically, chronic cerebral hypoperfusion disrupts the self-cannibalization mechanism of autophagy via altered expression of autophagy-specific proteins, Beclin-1, LC3 and P62. The deregulated autophagy pathway causes neuronal loss, hippocampal shrinkage, and ultimate loss in synaptic plasticity. The vascular dementia models typically exhibit downregulated anti-apoptotic Bcl-2 and upregulated pro-apoptotic Bax, cleaved caspase-3, and cleaved-PARP levels in the brain, for which modulated p38 MAPK and JNK phosphorylation pathways play a vital role. Endoplasmic stress-induced apoptosis, calcium overload and glutamate excitotoxicity in combination with ASK1-MAPK signaling mechanism also contribute to the cerebrovascular pathology. Vascular injury reduces neurological scores and increases the infarct volume, DNA damage and neuronal apoptosis in ischemia/reperfusion injury. Additionally, synergistic and additive interactions between inflammasome, autophagy and apoptotic signaling pathways augment symptoms of vascular neurodegeneration. Overall, the current review enlightens the key risk factors and underlying mechanism triggering vascular dementia. The review additionally informs the challenges associated while treating vascular dysfunction, and highlights the need for targeted drugs for reducing cerebrovascular damage.

Protecting against vascular disease in brain

Cerebral Microvascular Dysfunction and Neurodegeneration in Dementia

Recent Progress in Vascular Aging: Mechanisms and Its Role in Age-related Diseases

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

Impact of the Renin–Angiotensin System on the Endothelium in Vascular Dementia: Unresolved Issues and Future Perspectives

Cerebral Vascular Disease and Neurovascular Injury in Ischemic Stroke

Cerebrovascular inflammation: A critical trigger for neurovascular injury?

Early and enduring: Targeting the endothelium for blood-brain barrier protection

Endothelial Dysfunction in Neurodegenerative Diseases

Advances in the Role of Endothelial Cells in Cerebral Small Vessel Disease

Interplay between Brain Pericytes and Endothelial Cells in Dementia

Inflammation, apoptosis and autophagy as critical players in vascular dementia

Train the Vessel, Gain the Brain: Physical Activity and Vessel Function and the Impact on Stroke Prevention and Outcome in Cerebrovascular Disease

The Pathobiology of Vascular Dementia

Dysfunction of Cerebrovascular Endothelial Cells: Prelude to Vascular Dementia

Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders

Molecular and Cellular Mechanisms of Neuroprotection by Vascular Endothelial Growth Factor.

Neurovascular dysfunction in vascular dementia, Alzheimer’s and atherosclerosis

Prevention of Vascular Contributions to Cognitive Impairment and Dementia: The Role of Physical Activity and Exercise

The Neurovasculome: Key Roles in Brain Health and Cognitive Impairment: A Scientific Statement From the American Heart Association/American Stroke Association

Mechanisms that Result in Damage During and Following Cerebral Ischemia